Alfa Cytology offers specialized radiolabeling and antibody-radionuclide conjugate development to advance radiopharmaceutical and nuclear medicine research.

About Vivos Inc. Vivos Inc. is a clinical-stage medical device company developing RadioGel ®, a precision radiotherapy hydrogel for human and veterinary oncology applications. IsoPet ® is commercially ...

The procedure uses radioactive “tracers” injected into your bloodstream that are viewed under specialized imaging equipment. In the case of detecting birth defects, the scan is performed early in life ...

MADRID -- Radiographic progression-free survival (rPFS) in metastatic castration-resistant prostate cancer (mCRPC) doubled when patients received a radionuclide ligand targeting prostate-specific ...

Since its approval in 2018 by the US Food and Drug Administration, peptide receptor radionuclide therapy (PRRT) has become a mainstay in the treatment of neuroendocrine tumors. Lutetium-177-DOTATATE, ...

Learn how radiopharmaceuticals are transforming cancer treatment and creating new opportunities for biotech and pharma ...

Nuclear medicine therapy uses radiopharmaceuticals targeting specific tumours, such as thyroid, lymphomas or bone metastases, delivering radiation to tumorous lesions as part of a therapeutic strategy ...

The Group is led by Prof. Gareth Law and Dr Gianni Vettese is the group's Senior Researcher. The group moved to the University of Helsinki Radiochemistry Unit in late 2018 from the University of ...

If you would like to learn more about the IAEA’s work, sign up for our weekly updates containing our most important news, multimedia and more. Nuclear medicine plays a very important role in the ...